Medicinal – Page 159

Chlorophyllum molybdites-synthesized manganese oxide nanoparticles (MnO-NPs): morphology, biocompatibility, and anticancer properties against liver cancer (HepG2) cell line

mycolabadmin

Researchers successfully created tiny manganese oxide particles using a wild mushroom called Chlorophyllum molybdites through an environmentally friendly process. These nanoparticles showed strong cancer-fighting ability against liver cancer cells and were effective against a parasite that causes leishmaniasis. The particles were safe for human use with minimal damage to healthy blood cells, making them promising candidates for developing new cancer and parasitic disease treatments.

Presynaptic hyperexcitability reversed by positive allosteric modulation of a GABABR epilepsy variant

mycolabadmin

Researchers studied three genetic mutations in GABA_B receptors that cause severe epilepsy and developmental problems in children. They found that these mutations prevent the receptors from reaching the cell surface and cause excessive calcium buildup in nerve terminals, leading to overexcitability. Using a special drug compound that enhances GABA_B receptor activity, the team was able to reverse these harmful effects, offering a potential new treatment strategy for affected patients.

Rediscovery of viomellein as an antibacterial compound and identification of its biosynthetic gene cluster in dermatophytes

mycolabadmin

Researchers discovered that dermatophytes, fungi that cause common skin infections like athlete’s foot, produce a red pigment called viomellein that kills bacteria. By studying the genes responsible for making this compound, scientists found that most dermatophytes produce it, which may help explain how these fungi establish infections on skin despite the presence of protective bacteria. This discovery opens new possibilities for understanding skin infections and potentially developing new treatments.

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori

mycolabadmin

Scientists developed a new way to test antifungal drugs using silkworms instead of expensive and ethically problematic mammal studies. They infected silkworms with mucormycosis-causing fungi and found that the infections behaved similarly to human cases, especially when they simulated human risk factors like steroid use and iron overload. The silkworm model successfully demonstrated that existing antifungal drugs work, while also revealing differences in fungal virulence that were linked to specific surface proteins.

Superficial Fungal Infections in Children—What Do We Know?

mycolabadmin

Fungal infections of the skin, hair, and nails are increasingly common in children worldwide, especially in warm, humid climates and in crowded living conditions. These infections are caused by germs that live on the skin and can spread through contact with infected people or animals. Children are particularly vulnerable due to their developing immune systems, but most infections are treatable with topical creams or oral medications, with terbinafine being the most effective option currently available.

Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction

mycolabadmin

This study found that regular exercise helps protect the brain of diabetic people from cognitive decline by boosting a protein called NDRG2 in astrocytes (brain support cells). The research shows that NDRG2 works by blocking harmful immune responses that damage synapses (connections between brain cells). In diabetic mice, exercise improved memory and learning ability while increasing NDRG2 levels, while blocking this protein reversed these benefits.

Epidemiological Profile of Otomycosis at the Peace Hospital of Ziguinchor (Senegal)

mycolabadmin

This study examined fungal ear infections (otomycosis) in a hospital in Senegal, finding that 85% of suspected cases were confirmed as fungal infections. The most common culprits were Aspergillus mold and Candida yeast species. The research emphasizes that proper fungal identification is crucial for effective treatment, as doctors might otherwise prescribe unnecessary antibiotics that don’t work against fungi.

Speciation analysis of fungi by liquid atmospheric pressure MALDI mass spectrometry

mycolabadmin

Scientists developed a fast new method using a technique called LAP-MALDI mass spectrometry to identify dangerous fungal infections within minutes instead of days. The method analyzes the unique fatty acids and proteins in fungal cells to distinguish between different species. This could help doctors quickly identify which fungal infection a patient has and choose the right treatment, potentially saving lives.

Invasive Saprochaete capitata Infection in an Immunocompromised Patient With Acute Myeloid Leukemia: A Case Report

mycolabadmin

A 46-year-old man with blood cancer developed a serious fungal infection caused by Saprochaete capitata during chemotherapy. This rare but dangerous fungus was found in his blood and lungs, causing fever and breathing problems. The patient was successfully treated with a combination of two antifungal medications and fully recovered, though this infection typically has a high death rate.

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient

mycolabadmin

A 5-year-old girl with a serious joint disease called systemic juvenile idiopathic arthritis developed a dangerous fungal infection in her nasal cavity and brain area. The fungal infection, caused by a mold organism called Lichtheimia, occurred because her immune system was severely weakened by medications used to treat her arthritis. Doctors treated the infection with antifungal drugs and surgery, and the patient eventually recovered by switching to a different arthritis medication. This case highlights how the strong medications needed to control some childhood arthritis can unexpectedly cause serious fungal infections.

Research Topic: Medicinal